Rheumatoid Arthritis Stories
For sufferers of rheumatoid arthritis (RA), cooking tasks can be both difficult and dangerous. However, a new assistive technology invented by a Queensland University of Technology (QUT) student offers a safe way for people to lift cookware, relying on the strength of their forearms. Patients with early rheumatoid arthritis (RA) who are current smokers were less likely to achieve good response to methotrexate (MTX) and tumor necrosis factor (TNF) inhibitors than those who never smoked. The risk of having a heart attack is 60 per cent higher just a year after a patient has been diagnosed with rheumatoid arthritis, according to research published in the December issue of the Journal of Internal Medicine. A new study determined that African Americans who smoke cigarettes have a higher risk of developing rheumatoid arthritis (RA). Positive outcomes in rheumatoid arthritis (RA) are closely linked to early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDs). Three out of five TNF blockers tested were found to reduce the risk of Alzheimer's disease in Rheumatoid arthritis patients, a study said. Rheumatoid arthritis patients who have a tough time using the computer keyboard might end up seeking potentially more destructive ways of putting their fingers to the keyboard. Bortezomib, a biologic drug used to treat bone marrow cancer may help in treating rheumatoid arthritis. Greek researchers conducted the study on animal models to test the effectiveness of the disease. A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). A study conducted at Copenhagen University Hospital showed that treatment of rheumatoid arthritis (RA) with disease modifying antirheumatic drugs (DMARDs), glucocorticoids, biologic agents, or a combination of agents significantly reduced radiographic evidence of joint destruction, with a relative effect of 48%óˆž´% as compared with placebo. There is an association between taking statins (lipid lowering drugs), and reduced risk of developing the chronic inflammatory disease, rheumatoid arthritis. These are the findings of a study by Gabriel Chodick and colleagues, published in this week's PLoS Medicine. New criteria for rheumatoid arthritis (RA), published in the Annals of Rheumatic Diseases, could prevent thousands of people from developing disabling late stage disease, by redefining how RA should be classified.